Skip to main content
Equibles
XERI logo

XERI · Xeriant, Inc. · Metrics

Track XERI — free

Use XERI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research XERI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.01 +0.00 (+2.27%) At close · Nov 12
Rebalance outlook locked
Going-concern doubt — flagged Sep 28, 2026

Substantial doubt about the company's ability to continue as a going concern.

“The Company has incurred net losses and negative cash flow from operations since inception. These factors, and the need for additional financing in order for the Company to meet its business plans, raises substantial doubt about the Company's ability to continue as a going concern.”
View the 10-K filed Sep 28, 2026
Market Cap
$9.78M
Shares
1.09B
Volume · Nov 12 1.78M Avg daily vol (3M) 1.72M

XERI metrics

72 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.01
Market cap
$9.78M

Price action

23 metrics
Price change (1W)
-4.3%
Price change (30D)
-8.3%
Price change (3M)
-28.5%
Price change (6M)
-48.2%
Price change (YTD)
-12.0%
Price change (1Y)
-2.2%
Trailing year
Price change (5Y)
-93.2%
52-week high
$0.03
52-week low
$0.01
Change from 52-week high
-64.8%
Change from 52-week low
+76.0%
Annualized volatility
162.9%
Annualized volatility (3M)
71.3%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
-0.1
RSI (14D)
36.2
Price vs SMA 50
-10.6%
Price vs SMA 200
-22.0%
Avg volume (3M)
1.72M
Relative volume
1.9
Average dollar volume
$18,029

Company

3 metrics
Sector
Industrials
Industry
Aerospace & Defense
Shares outstanding
1.09B

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
120.0×
reciprocal yield 0.8%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
4.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
72.1%
Operating margin
-405.2%
Trailing 12 months
Net margin
-1,052.4%
Gross profit (TTM)
$57,466
Operating profit (TTM)
−$1.06M
Net income (TTM)
$392,278
Trailing 12 months
Diluted EPS (TTM)
$0.00
FCF margin
—
Effective tax rate
3.9%

Per share

11 metrics
Revenue per diluted share (TTM)
$0.00
Gross profit per diluted share (TTM)
$0.00
Operating profit per diluted share (TTM)
$0.00
EBITDA per diluted share (TTM)
$0.00
Net income per diluted share (TTM)
$0.00
Operating cash flow per diluted share (TTM)
$0.00
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.00
Stock compensation per diluted share (TTM)
$0.00
Book value per share
$0.00

Growth

11 metrics
Revenue growth YoY
-100.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$79,665
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+34.7%
Year over year · more shares
Revenue CAGR (3Y)
-69.3%
Revenue CAGR (5Y)
-45.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
394.4%
Debt / equity
—
Current ratio
0.0
EBITDA (TTM)
−$1.06M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
-15.4
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$87,594
Total assets
$99,467
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$791,756
Capital expenditures (TTM)
$0
R&D (TTM)
$99,905
SG&A (TTM)
−$3,361
Stock compensation (TTM)
$256,500
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
1
13F filer change QoQ
0
Institutional ownership
0.0%
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
0.0%
Active holders' share change QoQ
+0.0%
Holder tenure
14.0
Price vs estimated holder cost
-65.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
19 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1481504 CUSIP 98422N103 13F (30d) 1 filings 1 filers Visit website Investor relations